跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

How AI Is Changing Cancer Drug Discovery

1Why Cancer Drug Discovery Is So Hard2What AI Can and Cannot Do Here3Finding the Right Target4Designing Molecules with AI5Testing, Trials, and Real-World Impact6What's Next and What to Watch
What AI Can and Cannot Do Here

Prediction Is Not Understanding

3 / 3
Take the worked example seriously, because it is where the whole chapter lands. A score of 0.92 does not mean the compound will work. It means the compound looks more like the actives in the training set than like the inactives. If that training set was dominated by one chemical family, the model may just be recognizing that family. So the score buys the compound a place in the test queue, and nothing more. That is why the lab does not become optional — an experiment is the only step that tests the biological claim itself rather than a statistical stand-in for it.
0:00 / 0:00

A model's output is a statement about similarity to past data, not a statement about biology. That gap is why experiments stay in the loop and why AI's practical role is to prioritize experiments rather than replace them.

Three limits that keep experiments essential

  • Bias: a model trained on one population or cancer subtype loses accuracy on others, often without any visible warning.
  • Uncertainty: scores are probabilities, and a confident-looking number can rest on very little evidence.
  • The prediction–reality gap: a statistical pattern in data is not the same as a mechanism in a living tumor, and biology can change underneath it.

What a high score actually tells you

Suppose a model scores a new compound at 0.92 for activity against a target. The honest reading is: this compound resembles the active compounds in the training set more than it resembles the inactive ones. It does not say the compound will bind, that it will reach a tumor, that it will be safe, or that the resemblance is causal. If the training set happened to contain many compounds from one chemical family, the model may simply be recognizing that family. The score earns the compound a place in the test queue — nothing more.

The practical takeaway

Treat AI as a way to spend scarce laboratory capacity well. It is most useful where the candidate space is enormous and experiments are expensive — which is precisely the situation in cancer drug discovery.

上一页3 / 3下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion